Amphastar Pharmaceuticals (AMPH) Change in Cash (2013 - 2026)

Amphastar Pharmaceuticals' Change in Cash history runs 14 years deep, the most recent figure standing at $762000.0 for Q1 2026.

• In Q1 2026, Change in Cash fell 97.56% year-over-year to $762000.0; the TTM figure through Mar 2026 stood at -$11.8 million (up 35.52% YoY), while the FY2025 annual figure was $18.6 million, up 153.9% from the prior year.
• Change in Cash was $762000.0 for Q1 2026 at Amphastar Pharmaceuticals, up from -$46.1 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $119.8 million in Q3 2023 to a low of -$126.5 million in Q4 2023.
• Historically, Change in Cash has averaged $2.6 million across 5 years, with a median of $762000.0 in 2026.
• Biggest YoY gain for Change in Cash was 1443.62% in 2023; the steepest drop was 10938.92% in 2023.
• A 5-year view of Change in Cash shows it stood at -$1.1 million in 2022, then sank by 10938.92% to -$126.5 million in 2023, then soared by 67.98% to -$40.5 million in 2024, then fell by 13.78% to -$46.1 million in 2025, then surged by 101.65% to $762000.0 in 2026.
• The last three Change in Cash figures came in at $762000.0 (Q1 2026), -$46.1 million (Q4 2025), and $28.6 million (Q3 2025), per Business Quant data.